Casdin Capital, LLC - SANA BIOTECHNOLOGY INC ownership

SANA BIOTECHNOLOGY INC's ticker is SANA and the CUSIP is 799566104. A total of 92 filers reported holding SANA BIOTECHNOLOGY INC in Q3 2021. The put-call ratio across all filers is 0.02 and the average weighting 0.4%.

Quarter-by-quarter ownership
Casdin Capital, LLC ownership history of SANA BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$2,902,500
-35.1%
750,0000.0%0.32%
-17.9%
Q2 2023$4,470,000
+381.2%
750,000
+1150.0%
0.39%
+1403.8%
Q4 2021$929,000
-31.2%
60,0000.0%0.03%
-23.5%
Q3 2021$1,351,000
+14.5%
60,0000.0%0.03%
+13.3%
Q2 2021$1,180,000
-41.2%
60,0000.0%0.03%
-50.0%
Q1 2021$2,008,00060,0000.06%
Other shareholders
SANA BIOTECHNOLOGY INC shareholders Q3 2021
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 34,239,018$673,139,0008.60%
Trustees of Columbia University in the City of New York 281,250$5,530,0008.17%
Crestline Management, LP 3,210,937$63,127,0005.44%
Omega Fund Management, LLC 843,750$16,588,0001.88%
Alphabet Inc. 2,812,500$55,294,0001.13%
SB Management Ltd 2,625,153$51,611,0000.61%
PUBLIC SECTOR PENSION INVESTMENT BOARD 4,508,111$88,629,0000.53%
HARVARD MANAGEMENT CO INC 468,749$9,216,0000.53%
Avidity Partners Management LP 778,597$15,307,0000.41%
Dragoneer Investment Group 1,500,000$29,490,0000.38%
View complete list of SANA BIOTECHNOLOGY INC shareholders